IRadimed Stock

IRadimed PEG

The PEG Ratio (Price/Earnings-to-Growth) of IRadimed (IRMD) as of Aug 3, 2026 is 2.76. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 3.23 — a change of -14.44% (lower).

PEG

2.76

YoY

-14.44%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of IRadimed is 2026 2.76 . PEG Ratio (Price/Earnings-to-Growth) of IRadimed was 2025 3.23 . It decreases by -14.44% lower compared to the previous year.
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

PEG Ratio (Price/Earnings-to-Growth) of IRadimed is 2.76 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of IRadimed changed from 3.23 to 2.76, representing a -14.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) IRadimed since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — IRadimed

All Key Metrics — IRadimed